GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Cartica Acquisition Corp (NAS:CITE) » Definitions » Cash, Cash Equivalents, Marketable Securities

Cartica Acquisition (Cartica Acquisition) Cash, Cash Equivalents, Marketable Securities : $0.04 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cartica Acquisition Cash, Cash Equivalents, Marketable Securities?

Cartica Acquisition's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 ($0.02 Mil) to Dec. 2023 ($0.01 Mil) but then increased from Dec. 2023 ($0.01 Mil) to Mar. 2024 ($0.04 Mil).

Cartica Acquisition's annual cash, cash equivalents, marketable securities increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($1.08 Mil) but then declined from Dec. 2022 ($1.08 Mil) to Dec. 2023 ($0.01 Mil).

Cartica Acquisition Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Cartica Acquisition's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cartica Acquisition Cash, Cash Equivalents, Marketable Securities Chart

Cartica Acquisition Annual Data
Trend Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
- 1.08 0.01

Cartica Acquisition Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.21 0.02 0.01 0.04

Cartica Acquisition Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Cartica Acquisition  (NAS:CITE) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Cartica Acquisition Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cartica Acquisition's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cartica Acquisition (Cartica Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Cartica Acquisition Corp (NAS:CITE) » Definitions » Cash, Cash Equivalents, Marketable Securities
Comparable Companies
CMCA PFTA TGAA CHAA CBRG BLUA TWOA HWEL PWUP NNAG PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
1775 I Street NW, Suite 900, Washington, DC, USA, 20006
Website
https://www.carticaspac.com
Cartica Acquisition Corp is a blank check company.
Executives
John F Levy director C/O WASHINGTON PRIME GROUP INC., 180 EAST BROAD STREET, COLUMBUS OH 43215
Kishore Kondragunta director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Suresh Guduru director, 10 percent owner, officer: Chief Executive Officer 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Kyle I. Parent director 3524 SILVERSIDE ROAD, SUITE 35B3524, WILMINGTON DE 19801
Rana Gujral director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Suresh Singamsetty director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Asif Ramji director 3399 PEACHTREE ROAD NE, SUITE 1900, ATLANTA GA 30326
Parul Bhandari director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Cartica Acquisition Partners, Llc 10 percent owner 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Steven J. Quamme director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Farida Khambata director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Sanjeev Goel director, officer: Chief Executive Officer 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
C. Brian Coad officer: COO and CFO 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Keki M. Mistry director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Subramanian Ramadorai director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006